Sierra World Equity Review

Is Vanguard quietly increasing the number of shares of Arena Pharmaceuticals from 7 million to 10 million, why does Vanguard think ARNA is is a GREAT investment now?

TOP FOUR REASONS -Arena Pharmaceuticals (ARNA) will become a $100 stock forecasts accurate phenom Sierra World Equity Review

Eisai and Arena Pharmaceuticals executives meeting in London prior to European Medicines Agency approval ventures Sierra World Equity Review

Sierra World Equity Review has contacted Pfizer to see if they may be willing to shed some more light or be willing to make any comments about their potential interest in the purchase of Arena Pharmaceuticals

Sierra World Equity Review anticipates that the European Medicines Agency will approve the marketing application for Lorcaserin and thereby increase massively the revenue opportunities for Arena Pharmaceuticals (ARNA)

Ok, so we told you that we believed that their was some exciting things coming Arena Pharmaceuticals way....so here it is....but before we get to it we just want to remind you that you heard it HERE FIRST!

breaking..is First Lady Michelle Obama to visit Arena HQ now that Belviq is approved to promote for adults Task Force action plan: "Solving the Problem of Childhood Obesity Within a Generation"

Sierra World Equity Review has very good news for the shareholders of Arena Pharmaceuticals (ARNA). We believe that Pfizer (PFE) and Arena Pharmaceuticals have been talking...

Sierra World Equity Review ventures that Japanese drug giant Eisai and it's CEO and President Chairman Naito will act swiftly to ensure that Eisai retains control of Belviq

Sierra World Equity Review believes that Bank of America (BAC) may be getting involved in the Arena Pharmaceuticals (ARNA) buyout saga!